Gene expression profiling in uveal melanoma: Two regions on 3p related to prognosis

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4254-4262

  Van Gils, Walter ^a   Lodder, Elisabeth M ^a   Mensink, Hanneke W ^a,b   Kiliç, Emine ^a   Naus, Nicole C ^a   Brüggenwirth, Hennie T ^a   Van Ijcken, Wilfred ^a   Paridaens, Dion ^b   Luyten, Gregorius P ^a,c   De Klein, Annelies ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CHROMOSOME 1; CHROMOSOME 3P; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UVEA MELANOMA; ADULT; AGED; CHROMOSOME 3; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 53449099872     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2033     Document Type: Article

References (37)

1. Prescher G, Bornfeld N, Friedrichs W, Seeber S, Becher R. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation. Cancer Genet Cytogenet. 1995;80(1):40-46.
2. Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 1997;19(1):22-28. (Pubitemid 27193716)
3. Kilic E, Naus NC, van Gils W, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005;46(7):2253-2257. (Pubitemid 43119466)
4. Tschentscher F, Husing J, Holter T, et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res. 2003;63(10):2578-2584. (Pubitemid 36608917)
5. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205-7209.
6. Naus NC, Zuidervaart W, Rayman N, et al. Mutation analysis of the PTEN gene in uveal melanoma cell lines. Int J Cancer. 2000;87(1):151-153. (Pubitemid 30368430)
7. Shaffer LG, Tommerup N. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger; 2005:130.
8. Naus NC, Verhoeven AC, van Drunen E, et al. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res. 2002;8(2):534-539.
9. Hopman AH, Ramaekers FC, Raap AK, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988;89(4):307-316.
10. van Dekken H, Pizzolo JG, Reuter VE, Melamed MR. Cytogenetic analysis of human solid tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes. Cytogenet Cell Genet. 1990;54(3-4):103-107.
11. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(Suppl1) S96-S104. (Pubitemid 41185642)
12. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002;99(10):6567-6572. (Pubitemid 34526173)
13. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107(8):1443-1449. (Pubitemid 30825848)
14. Callegaro A, Basso D, Bicciato S. A locally adaptive statistical procedure (LAP) to identify differentially expressed chromosomal regions. Bioinformatics. 2006;22(21):2658-2666. (Pubitemid 44642605)
15. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347(9010):1222-1225. (Pubitemid 26131850)
16. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 1998;83(2):354-359.
17. Foss AJ, Alexander RA, Hungerford JL, et al. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol. 1997;81(3):240-246; discussion 247-248.
18. Kilic E, van Gils W, Lodder E, et al. Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci. 2006;47(9):3703-3707. (Pubitemid 46044279)
19. Kilic E, Stijnen T, de Jong PT, et al. Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy. Arch Ophthalmol. 2005;123(10):1363-1367. (Pubitemid 41429736)
20. Worley LA, Onken MD, Person E, et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res. 2007;13(5):1466-1471. (Pubitemid 46450436)
21. Petrausch U, Martus P, Tonnies H, et al. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye. Published online March 23, 2007.
22. Cross NA, Ganesh A, Parpia M, et al. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye. 2006;20(4):476-481.
23. Blasi MA, Roccella F, Balestrazzi E, et al. 3p13 region: a possible location of a tumor suppressor gene involved in uveal melanoma. Cancer Genet Cytogenet. 1999;108(1):81-83. (Pubitemid 29019090)
24. Fuse N, Yasumoto K, Takeda K, et al. Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus. J Biochem (Tokyo). 1999;126(6):1043-1051. (Pubitemid 30014450)
25. Tachibana M, Takeda K, Nobukuni Y, et al. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat Genet. 1996;14(1):50-54. (Pubitemid 26301546)
26. Mouriaux F, Vincent S, Kherrouche Z, et al. Microphthalmia transcription factor analysis in posterior uveal melanomas. Exp Eye Res. 2003;76(6):653-661. (Pubitemid 36549022)
27. Selzer E, Wacheck V, Lucas T, et al. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res. 2002;62(7):2098-2103. (Pubitemid 34408458)
28. Garcia JA, Ou SH, Wu F, et al. Cloning and chromosomal mapping of a human immunodeficiency virus 1 "TATA" element modulatory factor. Proc Natl Acad Sci U S A. 1992;89(20):9372-9376.
29. Jensen KB, Watt FM. Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci U S A. 2006;103(32):11958-11963.
30. Li L, Bales ES, Peterson CA, Legerski RJ. Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet. 1993;5(4):413-417. (Pubitemid 23351316)
31. Nusse R, Varmus HE. Wnt genes. Cell. 1992;69(7):1073-1087.
32. Ikegawa S, Kumano Y, Okui K, et al. Isolation, characterization and chromosomal assignment of the human WNT7A gene. Cytogenet Cell Genet. 1996;74(1-2):149-152. (Pubitemid 26336510)
33. Mueller E, Smith M, Sarraf P, et al. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A. 2000;97(20):10990-10995. (Pubitemid 30751266)
34. Wang M, Liu YE, Greene J, et al. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene. 1997;14(23):2767-2774. (Pubitemid 27313408)
35. van der Velden PA, Zuidervaart W, Hurks MH, et al. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer. 2003;106(4):472-479. (Pubitemid 36966202)
36. Maat W, van der Velden PA, Out-Luiting C, et al. Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci. 2007;48(2):486-490. (Pubitemid 351260675)
37. Onken MD, Worley LA, Davila RM, Char DH, Harbour JW. Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens. J Mol Diagn. 2006;8(5):567-573.